中文名称：4-[5,6-二氢-2-(2-吡啶)-4H-吡咯并[1,2-b]吡唑-3-基]-7-[2-(4-吗啉)乙氧基]喹啉

英文名称：4-[5,6-二氢-2-(2-吡啶)-4H-吡咯并[1,2-b]吡唑-3-基]-7-[2-(4-吗啉)乙氧基]喹啉

SMILES：N1(CCOC2=CC=C3C(C4=C(CCC5)N5N=C4C6=NC=CC=C6)=CC=NC3=C2)CCOCC1

中文同义名：

4-[5,6-二氢-2-(2-吡啶基)-4H-吡咯并[1,2-B]吡唑-3-基]-7-[2-(4-吗啉基)乙氧基]喹啉; N-CYCLOPENTYL-Β-ALANINE; 4-[5,6-二氢-2-(2-吡啶)-4H-吡咯并[1,2-B]吡唑-3-基]-7-[2-(4-吗啉)乙氧基]喹啉; LY2109761, 一种新型的,选择性TGF-Β RECEPTOR TYPE I/II (TΒRI/II)双重抑制剂;

英文同义名：

LY2109761; Quinoline, 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-Morpholinyl)ethoxy]-; 4-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]quinoline; LY2109761/LY-2109761; LY210976; 4-[2-[4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxyethyl]Morpholine; 7-(2-morpholinoethoxy)-4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline; 4-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]quinoline LY 2109761;